5 Key Takeaways

• 1

  Optogenetics offers a promising approach for vision restoration in retinitis pigmentosa by targeting residual inner retinal neurons.

• 2

  Clinical trials demonstrate that optogenetic treatments can improve visual acuity and other visual functions in patients with advanced retinal degeneration.

• 3

  Intravitreal delivery of optogenetic therapies simplifies the procedure and expands the eligible patient population compared to subretinal surgery.

• 4

  Multiple clinical programs show that targeting different retinal cell types can yield complementary benefits in restoring vision.

• 5

  Future advancements in optogenetics will require addressing variability in patient responses and improving the resolution of restored vision.